What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His main research concerns Internal medicine, Fluorouracil, Cancer research, Dihydropyrimidine dehydrogenase and Epidermal growth factor receptor.
His studies in Internal medicine integrate themes in fields like Endocrinology, Surgery and Oncology.
The concepts of his Oncology study are interwoven with issues in Colorectal cancer, Capecitabine, Pathology, Breast cancer and Bevacizumab.
His Fluorouracil research is multidisciplinary, incorporating elements of Gastroenterology, Pharmacokinetics, Peripheral blood mononuclear cell and Antimetabolite.
His Dihydropyrimidine dehydrogenase research incorporates themes from Molecular biology, Biopsy, Dihydropyrimidine dehydrogenase deficiency and DPYD.
He has included themes like Epidermal growth factor, Signal transduction and Tyrosine-kinase inhibitor in his Epidermal growth factor receptor study.
His most cited work include:
- Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value (697 citations)
- Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. (373 citations)
- Population study of dihydropyrimidine dehydrogenase in cancer patients. (370 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Oncology, Cancer research, Fluorouracil and Pharmacology.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Endocrinology.
His Oncology research is multidisciplinary, incorporating perspectives in Cetuximab, Head and neck cancer, Capecitabine, Pathology and Breast cancer.
His Cancer research research focuses on subjects like Epidermal growth factor receptor, which are linked to Epidermal growth factor.
The concepts of his Fluorouracil study are interwoven with issues in Biochemistry and Antimetabolite.
His Pharmacology research includes elements of Methotrexate, Toxicity and Cytotoxicity.
He most often published in these fields:
- Internal medicine (49.77%)
- Oncology (29.86%)
- Cancer research (21.99%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (49.77%)
- Oncology (29.86%)
- Cancer research (21.99%)
In recent papers he was focusing on the following fields of study:
Gérard Milano mostly deals with Internal medicine, Oncology, Cancer research, Cetuximab and Cancer.
As part of his studies on Internal medicine, Gérard Milano often connects relevant areas like Single-nucleotide polymorphism.
His Oncology study incorporates themes from Toxicity, Breast cancer, Capecitabine and Chemotherapy.
His Cancer research study which covers Immunotherapy that intersects with Melanoma.
His work carried out in the field of Cetuximab brings together such families of science as Head and neck cancer, Antibody-dependent cell-mediated cytotoxicity, Epidermal growth factor receptor and Monoclonal.
As part of the same scientific family, Gérard Milano usually focuses on Cancer, concentrating on Bioinformatics and intersecting with Precision medicine and MEDLINE.
Between 2013 and 2021, his most popular works were:
- Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis (152 citations)
- Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation. (65 citations)
- The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors. (53 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Internal medicine, Oncology, Cancer research, Cetuximab and Cancer.
His research in Internal medicine intersects with topics in Gastroenterology and Pharmacology.
His studies deal with areas such as Head and neck squamous-cell carcinoma, Head and neck cancer, Capecitabine, DPYD and Single-nucleotide polymorphism as well as Oncology.
His biological study spans a wide range of topics, including Monoclonal antibody and Immune system, Immunotherapy.
His biological study deals with issues like Antibody-dependent cell-mediated cytotoxicity, which deal with fields such as Cellular immunity and Epidermal growth factor receptor.
Many of his research projects under Fluorouracil are closely connected to In patient with In patient, tying the diverse disciplines of science together.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
